Watch NRXS. Know when insiders buy.
One email the day a filing lands. Free.
NRXS
Neuraxis, INC
7.31
+0.17 +2.38%
USD · close Sep 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $91.8MP/E —DIV YIELD —FCF YIELD —REV TTM $5.3M +65.2%NET INCOME −$7.7MNET CASH $8.1M52W 2.31 – 8.81SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.9M | +115.7% | 85.9% | −$2.1M | −$2.1M | — | -0.19 | −$1M | — | — | Aug 11 |
| Q1 2026 · Mar 31 | $1.6M | +79.5% | 86.4% | −$1.7M | −$1.8M | — | -0.18 | −$1.2M | — | — | Aug 11 |
| Q4 2025 · Dec 31derived | $968K | +27.2% | 85.4% | −$1.7M | −$1.7M | — | -0.17 | −$1.9M | $6K | −$1.9M | Mar 19 |
| Q3 2025 · Sep 30 | $811K | +21.7% | 83.3% | −$2.1M | −$2.1M | — | -0.24 | −$1.4M | $0 | −$1.4M | Nov 10 |
| Q2 2025 · Jun 30 | $894K | +46.2% | 83.6% | −$1.7M | −$1.7M | — | -0.22 | −$1.5M | $7K | −$1.5M | Aug 11 |
| Q1 2025 · Mar 31 | $896K | +38.5% | 84.4% | −$2.3M | −$2.3M | — | -0.33 | −$1.6M | $18K | −$1.6M | Aug 11 |
| Q4 2024 · Dec 31derived | $761K | +43.2% | 86.2% | −$1.5M | −$1.4M | — | -0.21 | −$1.8M | $0 | −$1.8M | Mar 19 |
| Q3 2024 · Sep 30 | $667K | +39.6% | 85.4% | −$1.7M | −$1.8M | — | -0.25 | −$1.4M | $4K | −$1.4M | Nov 10 |
| Q2 2024 · Jun 30 | $612K | — | 88.0% | −$2.2M | −$2.9M | — | -0.42 | −$1.6M | $9K | −$1.6M | Nov 10 |
| Q1 2024 · Mar 31 | $647K | — | 88.4% | −$1.8M | −$2.1M | — | -0.32 | −$1.3M | $15K | −$1.3M | Nov 10 |
| Q4 2023 · Dec 31derived | $531K | — | 86.4% | −$1.6M | −$1.6M | — | 0.61 | −$2.6M | $16K | −$2.6M | Mar 20 |
| Q3 2023 · Sep 30 | $477K | — | 85.9% | −$3M | −$8.6M | — | -2.38 | −$2.8M | $3K | −$2.8M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $3.6M | 84.2% | −$7.8M | −$7.8M | -218.5% | -0.95 | −$6.4M | $31K | −$6.5M | — | — |
| FY2024 · to Dec 31 | $2.7M | 86.5% | −$7.2M | −$8.2M | -306.8% | -1.22 | −$6.1M | $28K | −$6.1M | — | — |
| FY2023 · to Dec 31 | $2.5M | 87.7% | −$6.7M | −$14.6M | -594.6% | -4.50 | −$6.7M | $31K | −$6.7M | — | — |
| FY2022 · to Dec 31 | $2.7M | 88.9% | −$3.4M | −$4.8M | -178.0% | -2.77 | −$2.3M | $1K | −$2.3M | — | — |
Every number comes from Neuraxis, INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.